In Spite of Challenging External Forces: Dr. Oetker and Coppenrath & Wiese Organically Expand by 3% and Achieve a Commendable, Impressive Outcome
Dr. Oetker, the international food company, has announced its financial results for the 2024 fiscal year, reporting sales in line with the previous year despite significant political and economic changes. The company generated approximately €4.3 billion in revenue, with around 65% of total sales coming from outside of Germany.
Dr. Albert Christmann, chairman of the international management of Dr. Oetker, expressed satisfaction with the company's performance in the 2024 fiscal year. He highlighted the company's success in Western Europe, where notable sales increases were recorded, particularly in the cakes and desserts category.
The company addressed the significantly increased cocoa prices by providing clear and consumer-friendly information on all packages. Dr. Oetker also expanded its Vitalis muesli range with Muesli of the Year Brownie Style and Vitalis Muesli without added sugar Crunchy Apple & Almond. In March, the company expanded its High-Protein Range with High Protein Milk Rice Cinnamon.
Investments in the 2024 fiscal year amounted to €184 million, an increase of €13 million from the previous year. A large portion of these investments went towards expanding capacities in international pizza plants. The Conditorei Coppenrath & Wiese division significantly increased its sales in the export business.
The food division's number of employees remained stable at 16,599 compared to the previous year. Löffelglück Milk Rice Natural became available in the chilled section in June 2024. Dr. Oetker also expanded its pizza range with Pizza Suprema in September 2024.
Looking ahead to 2025, Dr. Oetker expects a moderate sales growth, focusing on innovations, targeted actions in retail, and direct consumer communication. The company plans to further increase investments, particularly in the future areas of innovation, sustainability, and digitalization.
In a surprising announcement, it was revealed that Carl Oetker will succeed Dr. Christmann as chairman of the international management of Dr. Oetker starting May 1, 2025. Dr. Christmann is set to leave his position at the end of April 30, 2025.
Unfortunately, the search results do not provide specific information about the countries in Western and Eastern Europe where Dr. Oetker had its most successful sales in the years 2023 and 2024. However, it is clear that Dr. Oetker continues to thrive in the ever-changing global market, with a focus on innovation and consumer satisfaction.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Trump's Policies: Tariffs, AI, Surveillance, and Possible Martial Law
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
